Related Experiment Video
Updated: Jul 5, 2026
Neurotoxicity Assessment in Adult Danio rerio using a Battery of Behavioral Tests in a Single Tank
Published on: November 3, 2023
Behavioral and in vitro evaluation of tetrodotoxin tolerability for therapeutic applications
Lidia Morales1, Carmen Pérez-García, Elisabet Salas
1Servicio de Farmacología y Toxicología Experimental (SFT-SAI), Universidad San Pablo-CEU, Boadilla del Monte, Madrid, Spain.
Abstract:
Tetrodotoxin (TTX) injection is currently being studied in clinical trials for potential antinociceptive applications. This work tries to increase the knowledge of its biological tolerability by using a behavioral procedure that can detect aversive effects of drug treatments, as well as in vitro cytotoxicity studies in non-excitable cell systems. Place conditioning studies with Sprague-Dawley male rats showed that pharmacologically active TTX injections (2.5 microg/kg, subcutaneous) were devoid of negative reinforcing properties, the drug being able to prevent the aversive effect of the vehicle. Similarly, TTX was not cytotoxic by itself as evaluated with the neutral red test and the MTT assay in HepG2 cells incubated for 24h with TTX concentrations as high as 400 microM. The results support the idea that low doses of TTX can be well tolerated.
Insights
Tetrodotoxin (TTX) injections show promise for pain relief and appear well-tolerated. Studies in rats and cell cultures found no aversive effects or cytotoxicity, supporting the safety of low-dose TTX.
Area of Science:
- Pharmacology
- Neuroscience
- Toxicology
Background:
- Tetrodotoxin (TTX) is under investigation for its potential antinociceptive (pain-relieving) properties.
- Understanding the biological tolerability of TTX is crucial for its clinical application.
Purpose of the Study:
- To assess the aversive effects of TTX using behavioral methods.
- To evaluate the in vitro cytotoxicity of TTX in non-excitable cells.
Main Methods:
- Place conditioning studies were conducted with male Sprague-Dawley rats.
- In vitro cytotoxicity was assessed using the neutral red and MTT assays in HepG2 cells.
Main Results:
- Pharmacologically active doses of TTX (2.5 microg/kg, subcutaneous) did not exhibit negative reinforcing properties in rats.
- TTX demonstrated no inherent cytotoxicity in HepG2 cells, even at high concentrations (up to 400 microM) after 24-hour incubation.
Conclusions:
- Low doses of Tetrodotoxin appear to be well-tolerated from both behavioral and cellular perspectives.
- These findings support the continued investigation of TTX for antinociceptive applications.
Related Concept Videos
01:23Toxicity Testing in Animals
01:24Resting Membrane Potential
The Inside of a Neuron is More Negative
The membrane potential of a cell can be measured by inserting a microelectrode into a cell and comparing the charge to a reference electrode in the extracellular fluid. The...